Effect of clay-zwitterionic interactions in controlling the viscoelastic properties in organomodified clays.

Investigating the rheology of 2D materials such as clays is of growing interest in various applications as it dictates their flowability and structural stability. Clay minerals present unique rheological properties, especially when in suspension. This study explores the effect of functionalizing bentonite clay with betaines of variable carbon chain lengths on the rheological properties of clay slurries to analyze their interactions in suspension. The results show that these zwitterion-functionalized clays exhibit higher viscosity, storage moduli, and flow stresses due to the formation of three-dimensional networks and increased aggregation caused by intercalation. The structural properties of the clay slurries are also found to be pH-sensitive. Additionally, XRD and SEM analyses support the proposed intercalation of the clays. The findings suggest the potential application of small-chain betaine functionalized clays in engineering and energy applications. Overall, this study provides insight into predicting the stability and strength of functionalized clay suspensions.

Polymeric Materials for Hemostatic Wound Healing.

Hemorrhage is one of the greatest threats to life on the battlefield, accounting for 50% of total deaths. Nearly 86% of combat deaths occur within the first 30 min after wounding. While external wound injuries can be treated mostly using visual inspection, abdominal or internal hemorrhages are more challenging to treat with regular hemostatic dressings because of deep wounds and points of injury that cannot be located properly. The need to treat trauma wounds from limbs, abdomen, liver, stomach, colon, spleen, arterial, venous, and/or parenchymal hemorrhage accompanied by severe bleeding requires an immediate solution that the first responders can apply to reduce rapid exsanguinations from external wounds, including in military operations. This necessitates the development of a unique, easy-to-use, FDA-approved hemostatic treatment that can deliver the agent in less than 30 s and stop bleeding within the first 1 to 2 min at the point of injury without application of manual pressure on the wounded area.